{"schema_version":"secwatch.filing_event.v1","accession":"0001816590-23-000123","form_type":"8-K","ticker":"CMPS","cik":"0001816590","company_name":"COMPASS Pathways plc","filed_at":"2023-09-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.392841+00:00","generated_at":"2026-06-10T15:08:11.109039+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"COMPASS Pathways appoints Daphne Karydas to Board of Directors","bullets":["Appointment effective September 18, 2023; Karydas is President/CFO of Flare Therapeutics.","Received initial option for 52,000 ordinary shares (or ADSs) vesting over three years.","Annual cash retainers: $40,000 as director, $8,000 as audit/risk committee member.","Serves as Class III director; brings over 20 years biopharma financial and strategy experience.","No family relationships with directors/officers; no material transactions disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001816590-23-000123","json":"https://secwatch.observer/filing/0001816590-23-000123.json","markdown":"https://secwatch.observer/filing/0001816590-23-000123.md","text":"https://secwatch.observer/filing/0001816590-23-000123.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816590/000181659023000123/0001816590-23-000123-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816590/000181659023000123/cmps-20230913.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T15:08:11.109039+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d9f6e4e503","claim":"Daphne Karydas was appointed as Director at COMPASS Pathways plc.","evidence_excerpt":"On September 13, 2023, the board of directors (the “Board”) of COMPASS Pathways plc (the “Company”), upon the recommendation of its nominating and corporate governance committee, appointed Daphne Karydas to join the Board, effective September 1 8, 2023, and designated her as a Class III director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1816590/000181659023000123/0001816590-23-000123-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}